Opicapone in Parkinson's Disease: Real-World Data from a Portuguese Center

Eur Neurol. 2021;84(2):129-131. doi: 10.1159/000514544. Epub 2021 Apr 6.

Authors

Filipa Meira-Carvalho¹, Jorge Diogo Da Silva^{2

3}, Margarida Rodrigues¹

Affiliations

¹ Department of Neurology, Hospital of Braga, Braga, Portugal.
² Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.
³ ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.

PMID: 33823522
DOI: 10.1159/000514544

No abstract available

Publication types

Letter

MeSH terms

Antiparkinson Agents / therapeutic use
Humans
Levodopa
Oxadiazoles
Parkinson Disease* / epidemiology
Portugal / epidemiology

Substances

Antiparkinson Agents
Oxadiazoles
Levodopa
opicapone